[治疗儿童慢性髓性白血病]
1Department of Nursing Science, Hirosaki University Graduate School of Health Sciences.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
儿科慢性髓性白血病 (CML) 治疗正在发展. 本综述强调了2025年儿童指导方针,重点关注氨酸激酶抑制剂 (TKI) 和国际共识,超越了基于成人的策略.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性髓性白血病 (CML) 在儿童中很罕见.
- 儿童CML治疗历来依赖于成年人的数据.
- 儿科CML的独特特征需要定制的方法.
研究的目的:
- 从2025年开始,审查当前的儿科CML治疗策略.
- 强调需要专门针对儿科的指导方针.
- 纳入最近的临床试验发现和国际共识.
主要方法:
- 关于儿科CML治疗的文献综述.
- 专注于来自日本的临床试验结果.
- 分析国际儿科CML工作组指南.
主要成果:
- 用氨酸激酶抑制剂 (TKI) 治疗CML的重大进展.
- 人们越来越认识到儿科CML的独特生物学和临床特征.
- 目前正在制定专门针对儿科的治疗建议.
结论:
- 儿科CML治疗需要特殊的指导方针,与成人治疗方案不同.
- 国际合作和区域数据 (如日本) 对于推进儿科CML护理至关重要.
- 儿科CML管理的格局正在向针对年轻患者的量身定制,基于证据的策略转变.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.6K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.4K
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
